TL;DR
This study investigated the impact of proton radiation therapy (PRT) on the nutritional status of cancer patients. The findings suggest that PRT may have a less detrimental effect on nutritional parameters compared to conventional radiotherapy, with minimal significant changes observed in dietary intake, strength, anthropometry, and key blood markers.
What Problem Does This Paper Address?
Cancer patients are highly susceptible to malnutrition, which can negatively impact treatment efficacy, quality of life, and increase complication risks. While radiation therapy is a crucial cancer treatment, it can exacerbate malnutrition through various toxicities. Proton radiation therapy (PRT) is a more advanced form of radiotherapy that aims to reduce toxicity by precisely targeting tumors and minimizing damage to surrounding healthy tissues. However, there's a relative lack of real-world data on how PRT specifically affects the nutritional status of cancer patients. This paper aims to fill that gap by evaluating changes in nutritional markers before and after PRT in a cohort of hospitalized cancer patients.
Methods
This was an observational study conducted at the Hefei Ion Medical Center. The researchers collected data from 47 hospitalized cancer patients undergoing PRT between December 2021 and August 2022. Nutritional assessments were performed at the beginning and end of treatment. Key methods included:
- Nutritional Risk Screening 2002 (NRS 2002): To assess the risk of malnutrition.
- Patient Generated Subjective Global Assessment (PG SGA): A more detailed assessment of nutritional status, classifying patients as well-nourished, moderately malnourished, or severely malnourished.
- 24-hour Dietary Survey: To quantify daily energy and protein intake.
- Handgrip Strength (HGS) Test: To measure skeletal muscle function, using an electronic dynamometer.
- Anthropometric Measurements: Including weight, height, Body Mass Index (BMI), triceps skinfold thickness (TSF), mid-upper arm circumference (MUAC), and mid-upper arm muscle circumference (MAMC).
- Hematological Parameters: Measuring total protein (TP), serum albumin (ALB), and hemoglobin (HGB).
Statistical analysis involved paired t-tests and Wilcoxon signed-rank tests for continuous variables, and chi-squared or Fisher's exact tests for categorical variables, with a significance level of p < 0.05.
Datasets
Not discussed in the paper. The study utilized data collected from 47 patients at the Hefei Ion Medical Center.
Key Insights and Ideas
- PRT's Milder Impact: The most significant takeaway is that PRT appears to have a less pronounced negative effect on the nutritional status of cancer patients compared to what might be expected from conventional radiotherapy. This aligns with PRT's known advantage of reduced toxicity.
- Nutritional Risk vs. Malnutrition: While the rate of nutritional risk and malnutrition showed a slight increase from the beginning to the end of PRT, these changes were not statistically significant. This suggests that PRT, while not eliminating nutritional challenges, might not drastically worsen them.
- Weight Stability: Despite some patients experiencing weight loss, the overall median weight change was 0%, indicating that PRT did not lead to widespread significant weight loss in this cohort. This is a crucial finding, as weight loss is a common and concerning symptom of malnutrition.
- Preserved Muscle Function: The handgrip strength (HGS) test, a marker of muscle function, showed no significant decrease, suggesting that PRT might help preserve muscle strength during treatment.
- Hematological Markers: While total protein and albumin levels remained stable, hemoglobin levels actually showed a slight, statistically significant increase at the end of PRT. This is an unexpected finding and warrants further investigation, potentially indicating improved overall health or reduced inflammation.
Key Results
- Nutritional Risk: Increased from 4.3% at onset to 6.4% at the end of PRT.
- Malnutrition (PG SGA B or C): Increased from 12.8% at onset to 27.7% at the end of PRT. However, these changes were not statistically significant (p > 0.05).
- Weight Change: Median percentage change was 0.00% (range -5.3% to 9.2%). 42.6% of patients experienced weight loss, but only 2.1% lost over 5%.
- Dietary Intake: Average daily energy and protein intake showed no significant change between onset and end of PRT (p > 0.05).
- Handgrip Strength (HGS): Average HGS decreased slightly from 31.35 ± 10.06 kg to 30.16 ± 9.87 kg, but this was not statistically significant (p > 0.05).
- Anthropometry: No significant differences were observed in weight, BMI, MUAC, MAMC, or TSF (all p > 0.05).
- Hematological Parameters: Total protein and albumin showed no significant changes (p > 0.05). Hemoglobin levels were significantly higher at the end of PRT compared to the onset (p < 0.05).
Limitations and Future Work
The authors acknowledge several limitations:
- Small Sample Size: The study included only 47 patients, which may limit the ability to draw definitive conclusions about the effect of PRT.
- Variability in Patient Profiles: Malnutrition prevalence varies significantly by tumor type, stage, and location. Future research should investigate these effects separately.
- Limited Hematological Markers: The chosen hematological parameters (TP, ALB, HGB) are less sensitive indicators of nutritional status. More dynamic markers like prealbumin, retinol-binding protein, and transferrin should be included in future studies.
- Lack of Comparison Group: The study did not directly compare PRT patients with those receiving conventional photon radiation therapy. This comparison is crucial for definitively assessing PRT's advantages.
- Short Follow-up: The study only assessed nutritional status during treatment. Future work should include follow-up investigations on nutritional status, clinical outcomes, and adverse effects.
The authors suggest that future research should focus on these areas to provide a more comprehensive understanding of PRT's impact on cancer patients' well-being.
Summary updated